Public deck

Averin Capital (ACAA): the $284 million health-tech blank check with no company yet

ACAA gives investors a real trust account, a health-and-technology sponsor story, and almost no operating company to analyze. The question is whether that blank check becomes a disciplined de-SPAC or another dilution machine.